Randomized trial of a vascular care team vs education for patients with peripheral artery disease
CN Hess, A Daffron, MR Nehler, JT Morrison… - Journal of the American …, 2024 - jacc.org
… therapies that would impact lipid levels or lipid therapy, and … Patients in the vascular care
team group additionally met with a clinical pharmacist at baseline and had clinical pharmacist …
team group additionally met with a clinical pharmacist at baseline and had clinical pharmacist …
[HTML][HTML] Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic
… patients by measuring the impact of the interventions on lipid profiles in a clinically challenging
peripheral arterial disease … week delivered by the trained clinical pharmacist (MH) who …
peripheral arterial disease … week delivered by the trained clinical pharmacist (MH) who …
Underuse of prevention and lifestyle counseling in patients with peripheral artery disease
JS Berger, JA Ladapo - Journal of the American College of Cardiology, 2017 - jacc.org
… Peripheral artery disease (PAD) is a highly prevalent atherosclerotic syndrome with an estimated
global population burden of ∼200 million people (1)… the public health impact of lifestyle …
global population burden of ∼200 million people (1)… the public health impact of lifestyle …
Efficacy of a guideline-recommended risk-reduction program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease
MA Hussain, M Al-Omran, M Mamdani… - JAMA …, 2016 - jamanetwork.com
… Importance Patients with peripheral arterial disease (PAD) … , no studies have examined the
effect of a comprehensive risk-… However, the effects of blood pressure control, lipid control, …
effect of a comprehensive risk-… However, the effects of blood pressure control, lipid control, …
Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system
K Reynolds, KE Mues, TN Harrison, L Qian… - Vascular …, 2020 - journals.sagepub.com
… that statin therapy in patients with peripheral artery disease (PAD) is … peripheral artery disease
(PAD) is a common vascular … The prevalence of PAD rises with age and affects 12–20% of …
(PAD) is a common vascular … The prevalence of PAD rises with age and affects 12–20% of …
Pharmacist prescribing practices in a clinical pharmacy cardiac risk service
BA Todd, DG Lamprecht Jr… - … Health-System Pharmacy, 2016 - academic.oup.com
… demonstrating atherosclerosis, peripheral arterial disease, or … event of a patient safety
issue (eg, serious adverse effect, chest … The CPCRS developed a hybridized protocol for lipid …
issue (eg, serious adverse effect, chest … The CPCRS developed a hybridized protocol for lipid …
Evidence-based medical management of peripheral artery disease
GH Bevan, KT White Solaru - … , thrombosis, and vascular biology, 2020 - Am Heart Assoc
… for patients taking statins with those taking nonstatin lipid-… ) and found that those patients
taking nonstatin lipid therapy did not … The magnitude of this effect is clinically evident with the …
taking nonstatin lipid therapy did not … The magnitude of this effect is clinically evident with the …
A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease
D Sabater-Hernández, M Sabater-Galindo… - … & specialty pharmacy, 2016 - jmcp.org
… cluster RCTs, that assesses the impact of a clinical pharmacy service on any type of health-…
disease, coronary artery disease, cerebrovascular disease, and peripheral vascular disease …
disease, coronary artery disease, cerebrovascular disease, and peripheral vascular disease …
Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further …
MP Bonaca, P Nault, RP Giugliano, AC Keech… - Circulation, 2018 - Am Heart Assoc
… evolocumab in patients with peripheral artery disease (PAD) as well as the effect on major …
manifestation of atherosclerotic vascular disease enjoy robust benefits from lipid lowering and …
manifestation of atherosclerotic vascular disease enjoy robust benefits from lipid lowering and …
Association of statin dose with amputation and survival in patients with peripheral artery disease
… on coronary artery disease and stroke data. The aim of this study is to determine the effect of
statin … lipid lowering, and the pleiotropic effects of statins, as well, on atherosclerotic plaque. …
statin … lipid lowering, and the pleiotropic effects of statins, as well, on atherosclerotic plaque. …